Syndivia was nominated laureate of the i-LAB 2015 in the category "création-développement". i-LAB is a nationwide contest of innovative companies supported by the French Ministry of Higher Education and Research. The prize includes €275k financial support for Syndivia's R&D program on the development of next-generation targeted cancer therapies.
